Funded Tech Companies
MeiraGTx
Based in New York, MeiraGTx is venture-backed, with investment from Oberland Capital.
Company Overview
Company Name
MeiraGTx
Company Status
Private & Independent
Industry
Life Sciences
Funding Rounds
Total Funding
Contact Information
Mailing Address
655 Third Avenue 1115
New York, NY 10017
USA
New York, NY 10017
USA
Phone
Website
Email Address
Company Background Information
Overview
MeiraGTx is a vertically integrated, clinical-stage genetic medicines company with a broad pipeline with four late-stage clinical programs. Each of these programs use local delivery of small doses resulting in disease modifying effects in both inherited and more common diseases, in the eye, Parkinson's disease and radiation-induced xerostomia. MeiraGTx uses its innovative technology in optimization of capsids, promoters and novel translational control elements to develop best in class, potent, safe viral vectors.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
7/7/2026
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Alexandria Forbes
Chief Medical Officer
Robert Zeldin
Chief Operating Officer
Richard Giroux
Chief Scientific Officer
Stuart Naylor
Vice President
Tassos Georgiadis
Vice President
Tim Randall
Vice President
Christine Sheehy
VP - Bus. Development
Penny Fleck
VP - Bus. Development
David Rubinstein
VP - General Counsel
Robert Wollin
Company Investors
- Oberland Capital (Michael Bloom)
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs